BioCryst on Friday said it will receive an initial $250 million from Italian pharmaceutical company Neopharmed Gentili for the European assets and rights related to Orladeyo, along with up to $14 ...

Apogee also narrowed its per-share earnings outlook to between $2.59 and $3.12 from between $2.54 and $3.19, and it now projects adjusted per-share earnings of $3.80 to $4.20, up from $3.55 to $4.10.

Troubled plane maker Boeing was given an upgrade by an analyst who said a turnaround effort will get the market to reassess ...

Lindsay's board has bumped up the company's quarterly dividend by 2.8%, to 37 cents from 36 cents. The new payout, equal to $1.48 a year, represents an annual yield of about 1.03% based on Thursday's ...